New Search

If you are not happy with the results below please do another search

3 search results for:

1

Ramping-up private gen AI within Pharma and Medtech organizations

/0 Comments/in
Ramping-up private gen AI within Pharma and Medtech organizations Especially for medical and commercial organizations, the integration of private bespoke generative AI solutions is becoming a game-changer. This blog post explores the strategic approach to implementing tailored AI solutions in the pharma industry, highlighting how FFI-Ventures can support organizations throughout this transformative journey. The step-wise [...]
2

Reflections on the Data+AI summit June 12/13, 2024

/0 Comments/in
Reflections on the Data+AI summit June 12/13, 2024 The Data+AI summit organized by Databricks in San Francisco yielded very valuable insights that supplement our learnings from work with more than 15 pharma and biotech organizations. Key themes that I took away: 1. Generative AI has confirmed potential, delivers value and can be a game changer [...]
3

Exploring JCA Timelines: Opportunities and Challenges

/0 Comments/in
Exploring JCA Timelines: Opportunities and Challenges for Pharma and Biotech In the evolving landscape of EU healthcare, the introduction of Joint Clinical Assessments (JCA) as part of the new Health Technology Assessment (HTA) regulations signifies a pivotal shift. These assessments are redefining Pharma and Biotech companies' approach to product evaluation and approval, presenting both significant [...]